Sep 28, 2023 / 01:00PM GMT
Presentation
Sep 28, 2023 / 01:00PM GMT
=====================
Corporate Participants
=====================
* David Simon Redfern
GSK plc - President of Corporate Development
* Deborah Jayne Waterhouse
GSK plc - CEO of ViiV Healthcare & President of Global Health
* Kimberly Smith
ViiV Healthcare Limited - Head of Global Research & Medical Strategy
* Nick Stone
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst
* Kerry Ann Holford
Joh. Berenberg
GSK PLC
(MEX:GSK1)
MXN
367.94
0 (0%)
Market Cap: 1.53 Tn
Enterprise Value: 1.89 Tn
PE Ratio: 14.78
PB Ratio: 4.11
GF Score: 75/100 GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript
Sep 28, 2023 / 01:00PM GMT
Release Date Price:
MXN305.05
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot